Clinical trial

Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer

NCT00579423

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-11-01

PhasePHASE2

Study timeline

Study start (unknown)2000-11-01Date precision: month

Registry last updated2023-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostateunresolved

Cancerunresolved

Interventions

QS21BIOLOGICAL

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

Capcurecollaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00579423 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.